Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 5/20 | 0.31 |
| ▸ | PPARD | Q03181 | 4/20 | 0.31 |
| ▸ | PPARA | Q07869 | 4/20 | 0.31 |
| ▸ | LMNA | P02545 | 4/20 | 0.31 |
| ▸ | F7 | P08709 | 4/20 | 0.31 |
| ▸ | F3 | P13726 | 4/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
| ▸ | FABP4 | P15090 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL434976 | 1.00 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL317104 | 1.00 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL23391756 | 0.85 | FASN (0.32) | — | |
| SCHEMBL7087446 | 0.85 | FASN (0.32) | — | |
| SCHEMBL7087442 | 0.85 | FASN (0.32) | — | |
| SCHEMBL3784841 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL3784843 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL4115693 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL3788506 | 0.80 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA | |
| SCHEMBL29080445 | 0.80 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388755-A1 | PROBE FOR DETECTING CARBAPENEM-RESISTANT BACTERIA AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2025-12-25 | — | — | US | disclosed |
| US-12421393-B2 | Probe for detecting carbapenem-resistant bacteria and use thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2025-09-23 | — | — | US | disclosed |
| US-11465997-B2 | Synthesis of disorazoles and analogs thereof as potent anticancer agents | WILLIAM MARSH RICE UNIVERSITY (US) | 2022-10-11 | — | — | US | disclosed |
| US-20210277246-A1 | PROBE FOR DETECTING CARBAPENEM-RESISTANT BACTERIA AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2021-09-09 | — | — | US | disclosed |
| US-20210155616-A1 | SYNTHESIS OF DISORAZOLES AND ANALOGS THEREOF AS POTENT ANTICANCER AGENTS | WILLIAM MARSH RICE UNIVERSITY (US) | 2021-05-27 | — | — | US | disclosed |
| WO-2020027553-A1 | PROBE FOR DETECTING CARBAPENEM-RESISTANT BACTERIA AND USE THEREOF | 한양대학교 에리카산학협력단 | 2020-02-06 | — | — | WO | disclosed |
| EP-2081903-B1 | 2-AMINOCARBONYL-PYRIDINE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2014-05-07 | — | — | EP | disclosed |
| US-8664203-B2 | Thiazole derivatives and their use as P2Y12 receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2014-03-04 | — | — | US | disclosed |
| US-20130315825-A1 | TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS | WASHINGTON UNIVERSITY (US) | 2013-11-28 | — | — | US | disclosed |
| US-20130281406-A2 | THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2013-10-24 | — | — | US | disclosed |
| WO-2001021596-A1 | QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | ASTRAZENECA AB (SE) | 2001-03-29 | — | — | WO | disclosed |
| US-6140340-A | FOR TREATING FUNGAL INFECTIONS | HOECHST MARION ROUSSEL (FR) | 2000-10-31 | — | — | US | disclosed |
| WO-2000020413-A1 | NOVEL 2-[3-PHENYL-2-PROPENYL]-1,2,3,4-TETRAHYDROXYISOQUINOLINE DERIVATIVES, PREPARATION METHOD AND USE AS FUNGICIDES | AVENTIS PHARMA S.A. (FR) | 2000-04-13 | — | — | WO | disclosed |
| EP-0992502-A1 | 2-(3-Phenyl-2-propenyl)-1,2,3,4-tetrahydro-isochinolin derivatives, process for their preparation and their use as fungicides | HOECHST MARION ROUSSEL (FR) | 2000-04-12 | — | — | EP | disclosed |
| US-5840859-A | (Aminostyryl)pyridinium compounds for radiolabelling cell membranes | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0629604-B1 | Alicyclic phospholipase A2 inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0691343-A1 | CEPHALOSPORIN DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1996-01-10 | — | — | EP | disclosed |
| US-5436369-A | Alicyclic phospholipase A2 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-07-25 | — | — | US | disclosed |
| EP-0629604-A2 | Alicyclic phospholipase A2 inhibitors | Bristol-Myers Company (US) | 1994-12-21 | — | — | EP | disclosed |
| US-5216015-A | Androstanes | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388755-A1 | PROBE FOR DETECTING CARBAPENEM-RESISTANT BACTERIA AND USE THEREOF | KLK3, SI, KLK1 | ALDH1A1 660/4885SMN1; SMN2 2877/4885PPARG 4866/4885 |
| US-12421393-B2 | Probe for detecting carbapenem-resistant bacteria and use thereof | ABCC1, MGAM, PGLS | ALDH1A1 324/4885SMN1; SMN2 4077/4885PPARG 4845/4885 |
| US-20130315825-A1 | TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS | SNCA, PARK7, HTT | ALDH1A1 3495/4885SMN1; SMN2 533/4885PPARG 570/4885 |
| US-11465997-B2 | Synthesis of disorazoles and analogs thereof as potent anticancer agents | CD47, DUT, CD99 | ALDH1A1 202/4885SMN1; SMN2 3938/4885PPARG 4159/4885 |
| US-20130281406-A2 | THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS | P2RY12, P2RY1, P2RY2 | ALDH1A1 614/4885SMN1; SMN2 3642/4885PPARG 260/4885 |
| US-20210155616-A1 | SYNTHESIS OF DISORAZOLES AND ANALOGS THEREOF AS POTENT ANTICANCER AGENTS | CD47, DUT, CD99 | ALDH1A1 202/4885SMN1; SMN2 3938/4885PPARG 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.